| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000227036.2 |
Ponatinib |
Thyroid carcinoma |
0.00421439 |
Resistant |
| ENSG00000227036.2 |
Ponatinib |
Breast invasive carcinoma |
0.007124879 |
Sensitive |
| ENSG00000227036.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.046774291 |
Resistant |
